Skip to main content
SEM logo

SEM

Select Medical Holdings Corp
$16.51 -0.02 (-0.12%) At close · Jun 30
Market Cap
$2.05B
Shares
124,016,800

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$5.45B +5.1%
FY2025 Revenue FY2016–FY2025
Net Income
$146.22M -31.7%
FY2025 Net Income FY2009–FY2025
Operating Margin
6.17% +1pp
FY2025 Operating Margin FY2016–FY2025
Diluted EPS
$1.16 -30.1%
FY2025 Diluted EPS FY2009–FY2025
Operating Cash Flow
$346.47M -33.1%
FY2025 Operating Cash Flow FY2009–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 (G) TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010 FY2009
$5.6B – $5.8B $5.52B $5.45B $5.19B $4.83B $4.61B $6.2B $5.53B $5.45B $5.08B $4.37B $4.22B
-$186.5M -$154.7M -$170.08M -$112.82M
$160.79M $154.41M $225.87M $170.19M $153.04M $146.98M $138.04M $128.46M $121.27M $114.05M $106.93M $92.05M $85.25M $76.92M $66.19M $62.35M $62.12M $72.41M
$1.6M $1.6M $1.6M $1.8M $29.5M $27.6M $29.6M $29.9M $17.4M
$140.3M $203.89M $208.74M $205.83M $202.65M $205.66M $212.58M $201.66M $160.01M $145.31M $104.98M $68.35M $64.39M $63.31M $71.52M $68.71M $70.98M
$5.2B $5.12B $4.92B $4.56B $4.49B $5.63B $5.05B $4.98B $4.66B $4.01B $3.92B $3.47B $2.78B $2.67B $2.61B $2.49B $2.15B $2B
$321.84M $336.17M $268.32M $267.24M $144.75M $713.77M $567.66M $471.88M $417.28M $355.88M $299.85M $274.79M $284.48M $301.44M $336.86M $310.72M $236.14M $235.84M
6.17% 5.17% 5.54% 3.14% 11.5% 10.26% 8.65% 8.21% 8.15% 7.11%
$476.47M $472.21M $475.98M $350.58M $916.42M $773.32M $684.46M $618.93M $515.89M $445.16M $379.77M $352.83M $365.83M $400.17M $382.24M $304.84M $306.82M
$117.21M $117.94M $128.61M $198.64M $169.11M $135.99M $153.01M $200.57M $198.49M $154.7M $170.08M $112.82M $85.45M $87.36M $94.95M $99.22M $112.34M $132.47M
$322K $92K
$54.52M $60.23M $40.81M $26.41M $44.43M $29.44M $24.99M $21.91M $21.05M $19.94M $16.81M $7.04M $2.48M $7.71M $2.92M -$440K
$258.66M $272.75M $174.77M $139.72M $35.27M $629.72M $456.47M $264.75M $235.55M $202.46M $180.73M $208.43M $203.8M $197.8M $243.55M $183.73M $123.99M
$55.08M $58.22M $44.78M $29.25M $16.72M $129.77M $111.87M $63.72M $58.61M -$18.18M $55.46M $72.44M $75.62M $74.79M $89.66M $70.97M $41.63M $37.52M
$133.53M $146.22M $214.04M $243.49M $158.99M $402.23M $259M $148.45M $137.84M $177.18M $115.41M $130.74M $120.63M $114.39M $148.23M $107.85M $77.64M $75.28M
2.68% 4.13% 5.05% 3.45% 6.48% 4.68% 2.72% 2.71% 4.06% 2.74%
$70.04M $68.31M $82.67M $56.24M $39.03M $97.72M $85.61M $52.58M $39.1M $43.46M $9.86M $5.26M $7.55M $8.62M $5.66M $4.92M $4.72M $3.61M
$265.89M $234.72M $153.39M $388.79M $250.1M $143.45M $133.29M $171.43M $111.89M $126.91M $117.29M $111.94M $145.72M $106.64M $77.32M $55.75M
$131.26M $139.82M $171.13M $197.8M $235.31M $416.53M $256.97M $148.45M $137.84M $148.23M $107.85M $86.56M
USD/shares $1.16 $1.66 $1.91 $1.23 $2.98 $1.93 $1.10 $1.02 $1.33 $0.88 $1.00 $0.91 $0.82 $1.05 $0.71 $0.49 $0.61
USD/shares $1.22 – $1.32 $1.16 $1.66 $1.91 $1.23 $2.98 $1.93 $1.10 $1.02 $1.33 $0.87 $0.99 $0.91 $0.82 $1.05 $0.71 $0.48 $0.61
shares 122.65M 124.61M 123.11M 124.63M 130.25M 129.78M 130.25M 130.17M 128.96M 127.81M 127.48M 129.03M 136.88M 138.77M 150.5M 159.18M
shares 122.65M 124.61M 123.11M 124.63M 130.25M 129.78M 130.28M 130.26M 129.13M 127.97M 127.75M 129.47M 137.05M 139.04M 150.73M 159.44M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2012–FY2025: $594.49M in dividends.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
Medical Care Facilities median 1.27×
EV/EBIT
Medical Care Facilities median 17.93×
P/E (TTM)
15.43×
Medical Care Facilities median 16.85×

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Critical Illness Recovery Hospital $2,477,814,000 $2,444,196,000 $2,299,773,000 $2,234,132,000 $2,246,772,000 $2,077,499,000 $1,836,518,000 $1,753,584,000
Critical Illness Recovery Hospitals $2,477,814,000 $2,444,196,000 $2,299,773,000 $2,234,132,000 $2,246,772,000 $2,077,499,000 $1,836,518,000 $1,753,584,000
Rehabilitation Hospital $1,288,954,000 $1,110,592,000 $979,585,000 $916,763,000 $849,340,000 $734,673,000 $670,971,000 $583,745,000
Rehabilitation Hospitals $1,288,954,000 $1,110,592,000 $979,585,000 $916,763,000 $849,340,000 $734,673,000 $670,971,000 $583,745,000
Outpatient Rehabilitation $1,284,873,000 $1,250,294,000 $1,188,914,000 $1,125,282,000 $1,084,361,000 $919,913,000 $1,046,011,000 $995,794,000
Concentra $1,838,081,000 $1,724,359,000 $1,732,041,000 $1,501,434,000 $1,628,817,000 $1,557,673,000

By Product & Service (USD)

Component 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Health Care Patient Service $4,915,292,000 $4,675,536,000 $4,340,344,000 $4,151,412,000 $5,782,800,000 $5,107,482,000 $5,040,712,000 $4,760,325,000
Health Care Patient Service Non-Medicare $3,353,343,000 $3,183,700,000 $2,855,335,000 $2,703,715,000 $4,363,830,000 $3,722,516,000 $3,626,580,000 $3,409,761,000
Health Care Patient Service Medicare $1,561,949,000 $1,491,836,000 $1,485,009,000 $1,447,697,000 $1,418,970,000 $1,384,966,000 $1,414,132,000 $1,350,564,000
Service Other $537,538,000 $511,569,000 $485,633,000 $457,767,000 $421,715,000 $424,231,000 $413,210,000 $320,933,000

Segment Operating Income

Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.

By Segment (USD)

Component 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31
Concentra $287,632,000 $258,529,000 $305,264,000 $162,515,000 $176,606,000 $150,678,000 $91,804,000
Rehabilitation Hospital $193,820,000 $170,220,000 $157,027,000 $125,476,000 $108,535,000 $84,826,000 $69,865,000
Critical Illness Recovery Hospital $182,150,000 $49,779,000 $214,899,000 $290,896,000 $204,105,000 $197,218,000 $206,936,000
Outpatient Rehabilitation $76,658,000 $69,197,000 $108,683,000 $50,155,000 $123,530,000 $114,810,000 $107,926,000

Operating Margin by Segment (%)

Component 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Critical Illness Recovery Hospital 7.9% 2.2% 9.6% 14% 11.1% 11.2%
Rehabilitation Hospital 19.8% 18.6% 18.5% 17.1% 16.2% 14.5%
Outpatient Rehabilitation 6.4% 6.1% 10% 5.5% 11.8% 11.5%
Concentra 15.6% 15% 17.6% 10.8% 10.8% 9.7%
Key facts CIK 1320414 CUSIP 81619Q105 13F (30d) 9 filings 9 filers Visit website